CAS 107703-78-6
:Glemanserin
Description:
Glemanserin, with the CAS number 107703-78-6, is a chemical compound that has been studied primarily for its potential therapeutic applications, particularly in the field of neuroscience. It is classified as a serotonin receptor antagonist, specifically targeting the 5-HT2A receptor, which plays a significant role in various neurological and psychiatric conditions. The compound is known for its ability to modulate serotonin activity, potentially influencing mood, cognition, and perception. Glemanserin has been investigated for its effects on conditions such as schizophrenia and other mood disorders. In terms of its physical properties, like many pharmaceuticals, it is typically characterized by its molecular weight, solubility, and stability under various conditions. Safety and efficacy profiles are crucial for any therapeutic agent, and ongoing research aims to elucidate the full spectrum of its pharmacological effects and potential side effects. As with any chemical substance, proper handling and adherence to safety guidelines are essential in both research and clinical settings.
Formula:C20H25NO
InChI:InChI=1S/C20H25NO/c22-20(18-9-5-2-6-10-18)19-12-15-21(16-13-19)14-11-17-7-3-1-4-8-17/h1-10,19-20,22H,11-16H2
InChI key:InChIKey=AXNGJCOYCMDPQG-UHFFFAOYSA-N
SMILES:C(O)(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3
Synonyms:- (+-)-1-Phenethyl-alpha-phenyl-4-piperidinemethanol
- 4-Piperidinemethanol, alpha-phenyl-1-(2-phenylethyl)-, (+-)-
- 4-Piperidinemethanol, α-phenyl-1-(2-phenylethyl)-
- Glemanserin
- Mdl 11939
- α-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
α-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol
CAS:Formula:C20H25NOPurity:95%Color and Shape:SolidMolecular weight:295.4186MDL 11,939
CAS:MDL 11,939 is a serotonergic drug that was developed for the treatment of depression. It has inhibitory properties on serotonin and dopamine receptors, as well as synergistic effects with other serotonergic drugs such as 5-HT concentrations. MDL 11,939 has been shown to have a pharmacological effect in the papillary muscles of rats and to affect locomotor activity. This drug may also be used to treat Parkinson's disease.Formula:C20H25NOPurity:Min. 95%Molecular weight:295.42 g/molGlemanserin
CAS:<p>Glemanserin (MDL11939) is a specific 5-HT2A antagonist with Ki values of 0.54 nM, 2.5 nM and 2.89 nM for rabbit, human and rat 5-HT2A.</p>Formula:C20H25NOPurity:99.93%Color and Shape:SolidMolecular weight:295.42





